Market Research Logo

Point of Care Testing Market, Global Forecast, By Diagnostics (Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker), Mode (Pre

Point of Care Testing Market, Global Forecast, By Diagnostics (Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker), Mode (Prescription-based Testing and OTC-based Testing), End Users (Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home), Regions (North America, Europe, Asia-Pacific Latin America and Middle East/Africa), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic Becton, Dickinson & Company and Johnson & Johnson)

Point of Care Testing Market is anticipated to be US$ 36 Billion, by 2024 experiencing a significant growth over the forecast period. The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry.

Point of Care Testing market is expected to witness substantial growth due to rising incidence of chronic diseases; rapidly growing middle class population in developing countries like China & India, Continued Expansion of Point of Care Including Self Testing and New Evolution in Point of Care Testing further boosts the demand for the industry over the forecast period.

Renub Research report titled “Point of Care Testing Market, Global Forecast, By Diagnostics (Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker), Mode (Prescription-based Testing and OTC-based Testing), End Users (Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home), Regions (North America, Europe, Asia-Pacific Latin America and Middle East/Africa), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic Becton, Dickinson & Company and Johnson & Johnson)” provides a complete analysis of Point of Care Testing Market.

By Diagnostics - Blood Glucose and Infectious Disease controls the Point of Care Testing Market

The report studies the market of the following Diagnostics segments: Blood Glucose, Cardiac Marker, Lipid Panel/Cholesterol, Blood Coagulation, Infectious Disease, Urinalysis, Drug of Abuse, Fecal Occult Blood, Pregnancy & Fertility and Tumor Marker.

By Mode – OTC-based Testing has Intense Future Ahead

The report studies the Point of Care Diagnostics market by Prescription-based Testing and OTC-based Testing.

By End Users – Hospital and Clinic Point of Care Testing Market have Bright Future

It is believed that in near future; Hospital Point of Care Testing Market will certainly rule the Point of Care Testing Market. The report provides a detailed competitive landscaping Market of Hospitals, Clinic, Laboratories, Assisted Living Healthcare Facilities and Home.

By Region – North America and Europe will drive the Point of Care Testing Market

North America and Europe together controls the Point of Care Testing Market. In addition; the report also provides the complete geographical analysis of Asia-Pacific Latin America and Middle East/Africa Point of Care Testing Market.

Companies Analysis

Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Quest Diagnostic, Becton, Dickinson & Company and Johnson & Johnson are some of the top companies operating in the Point of Care Testing; which has been studied thoroughly in the report.

All the 6 Companies Studied in the Report have been Studied from 3 Points

• Company Overview
• Business Portfolio
• Financial Insight
This market research report provides a complete analysis of the Point of Care Testing Market, Growth Drivers, Challenges, and their projections for the upcoming years.

By Testing Segments

• Blood Glucose
• Cardiac Marker
• Lipid Panel/Cholesterol
• Blood Coagulation
• Infectious Disease
• Urinalysis
• Drug of Abuse
• Fecal Occult Blood
• Pregnancy & Fertility
• Tumor Marker

By Mode

• Prescription-based Testing
• OTC-based Testing

By End Users

• Hospital
• Clinic
• Laboratories
• Assisted Living Healthcare Facilities
• Home
By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East/Africa

Key Companies Covered in the Report:

• Abbott Laboratories
• Siemens Healthineers
• Roche Diagnostics
• Quest Diagnostic
• Becton, Dickinson and Company
• Johnson & Johnson


1. Executive Summary
2. Global Point of Care Testing Market & Forecast
3. Market Share – Global Point of Care Testing
3.1 By Diagnostics
3.2 By Region
4. Diagnostics Segments – Point of Care Market (2010 – 2024)
4.1 Blood Glucose Testing Market
4.2 Cardiac Marker Testing Market
4.3 Lipid Panel/Cholesterol Testing Market
4.4 Blood Coagulation Testing Market
4.5 Infectious Disease Testing Market
4.6 Urinalysis Testing Market
4.7 Drug of Abuse Testing Market
4.8 Fecal Occult Blood Testing Market
4.9 Pregnancy & Fertility Testing Market
4.10 Tumor Marker Testing Market
5. By Mode - Global Point of Care Testing Market (2010 – 2024)
5.1 Prescription-based Testing
5.2 OTC-based Testing
6. By End User - Global Point of Care Testing Market & Forecast
6.1 Hospital
6.2 Clinic
6.3 Laboratories
6.4 Assisted Living Healthcare Facilities
6.5 Home
7. By Region - Global Point of Care Testing Market & Forecast
7.1 North America
7.2 Europe
7.3 Asia-Pacific
7.4 Latin America
7.5 Middle East/Africa (MEA)
8. Abbott Laboratories – Company Analysis
8.1 Overview
8.2 Business Portfolio
8.2.1 Point A
8.2.2 Point B
8.2.3 Point C
8.2.4 Point D
8.3 Financial Insight
9. Siemens Healthineers – Company Analysis
9.1 Overview
9.2 Business Portfolio
9.2.1 Point A
9.2.2 Point B
9.2.3 Point C
9.3 Financial Insight
10. Roche Diagnostics – Company Analysis
10.1 Overview
10.2 Business Portfolio
10.2.1 Point A
10.2.2 Point B
10.2.3 Point C
10.3 Financial Insight
11. Quest Diagnostic – Company Analysis
11.1 Overview
11.2 Business Portfolio
11.2.1 Point A
11.2.2 Point B
11.2.3 Point C
11.2.4 Point D
11.3 Financial Insight
12. Becton, Dickinson and Company – Company Analysis
12.1 Overview
12.2 Business Portfolio
12.2.1 Point A
12.2.2 Point B
12.2.3 Point C
12.2.4 Point D
12.3 Financial Insight
13. Johnson & Johnson – Company Analysis
13.1 Overview
13.2 Business Strategy
13.2.1 Point A
13.2.2 Point B
13.2.3 Point C
13.3 Financial Insight
14. Growth Drivers
14.1 Rise in Chronic Diseases Driving Demand
14.2 Continued Expansion of Point of Care Including Self Testing
14.2.1 The Promise of Point-of-Care Testing
14.2.2 Future of Point of Care Testing – The ‘Worried Well’
14.2.3 Theranostics – Companion Diagnostics
14.2.4 Hub and Spoke
14.2.5 Education
14.3 New Evolution Enhances Point of Care Testing Market
14.3.1 Point of Care Testing (POCT)
14.3.2 On the Market
14.3.3 Expanding Test Menu
14.3.4 Diabetes Tests
14.3.5 Chronic Kidney Disease
14.3.6 Oral Specimens
14.4 Point of Care Testing: A Step to the Future
14.4.1 Paradigm Shifts
14.4.2 Why Consider POCT?
14.4.3 Benefit of Point of Care Testing
14.4.4 The Future
15. Challenges
15.1 Manufacturing Obstacles in POC Testing Product Development
15.1.1 Avoiding Too Much, Too Soon
15.1.2 Closely Considering Materials and Environment
15.2 Point of Care (POC) Testing Barriers in Low & Middle Income Countries
15.2.1 Barriers to Adoption & Scale-up of POC Technologies
15.2.2 Technical, Administrative & Operational Barriers of Point of Care Tests
15.2.3 Health System Related Barriers of Point of Care Tests
15.2.4 Economic Barriers of Point of Care Tests
List of Figure
s
Figure 2-1: Global – Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 2-2: Global – Forecast for Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 3-1: By Testing – Point of Care Testing Market Share (%), 2010 – 2017
Figure 3-2: By Testing – Forecast for Point of Care Testing Market Share (%), 2018 – 2024
Figure 3-3: By Region – Point of Care Testing Market Share (%), 2010 – 2017
Figure 3-4: By Region – Forecast for Point of Care Testing Market Share (%), 2018 – 2024
Figure 4-1: Global – Blood Glucose Testing Market (Million US$), 2010– 2017
Figure 4-2: Global – Forecast for Blood Glucose Testing Market (Million US$), 2018 – 2024
Figure 4-3: Global – Cardiac Marker Testing Market (Million US$), 2010 – 2017
Figure 4-4: Global – Forecast for Cardiac Marker Testing Market (Million US$), 2018 – 2024
Figure 4-5: Global – Lipid Panel/Cholesterol Testing Market (Million US$), 2010 – 2017
Figure 4-6: Global – Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2018 – 2024
Figure 4-7: Global – Blood Coagulation Market (Million US$), 2010 - 2017
Figure 4-8: Global – Forecast for Blood Coagulation Market (Million US$), 2018 – 2024
Figure 4-9: Global – Infectious Disease Testing Market (Million US$), 2010 – 2017
Figure 4-10: Global – Forecast for Infectious Disease Testing Market (Million US$), 2018 – 2024
Figure 4-11: Global – Urinalysis Testing Market (Million US$), 2010 – 2017
Figure 4-12: Global – Forecast for Urinalysis Testing Market (Million US$), 2018 – 2024
Figure 4-13: Global – Drug of Abuse Testing Market (Million US$), 2010 – 2017
Figure 4-14: Global – Forecast for Drug of Abuse Testing Market (Million US$), 2018 – 2024
Figure 4-15: Global – Fecal Occult Blood Testing Market (Million US$), 2010 – 2017
Figure 4-16: Global – Forecast for Fecal Occult Blood Testing Market (Million US$), 2018 – 2024
Figure 4-17: Global – Pregnancy & Fertility Testing Market (Million US$), 2010 – 2017
Figure 4-18: Global – Forecast for Pregnancy & Fertility Testing Market (Million US$), 2018 – 2024
Figure 4-19: Global – Tumor Marker Testing Market (Million US$), 2010 – 2017
Figure 4-20: Global – Forecast for Tumor Marker Testing Market (Million US$), 2018 – 2024
Figure 5-1: Prescription-based Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 5-2: Forecast for Prescription-based Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 5-3: OTC-based Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 5-4: Forecast for OTC-based Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 6-1: Hospital - Point of Care Testing Market (Billion US$), 2010 - 2017
Figure 6-2: Forecast for Hospital - Point of Care Testing Market (Billion US$), 2018 - 2024
Figure 6-3: Clinic - Point of Care Testing Market (Billion US$), 2010 - 2017
Figure 6-4: Forecast for Clinic - Point of Care Testing Market (Billion US$), 2018 - 2024
Figure 6-5: Laboratories - Point of Care Testing Market (Billion US$), 2010 - 2017
Figure 6-6: Forecast for Laboratories - Point of Care Testing Market (Billion US$), 2018 - 2024
Figure 6-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Billion US$), 2010 - 2017
Figure 6-8: Forecast for Assisted Living Healthcare Facilities - Point of Care Testing Market (Billion US$), 2018 - 2024
Figure 6-9: Home - Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 6-10: Forecast for Home - Point of Care Testing Market (Billion US$), 2018 - 2024
Figure 7-1: North America - Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 7-2: Forecast for North America - Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 7-3: Europe - Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 7-4: Forecast for Europe - Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 7-5: Asia Pacific - Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 7-6: Forecast for Asia Pacific - Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 7-7: Latin America - Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 7-8: Forecast for Latin America - Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 7-9: Middle East/Africa - Point of Care Testing Market (Billion US$), 2010 – 2017
Figure 7-10: Forecast for Middle East/Africa - Point of Care Testing Market (Billion US$), 2018 – 2024
Figure 8-1: Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2011 – 2017
Figure 8-2: Forecast for Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2018 – 2024
Figure 9-1: Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2011 – 2017
Figure 9-2: Forecast for Siemens Healthineers ‘Healthcare’ Sales (Billion US$), 2018 – 2024
Figure 10-1: Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2011 – 2017
Figure 10-2: Forecast for Roche Diagnostics ‘Diagnostic’ Sales (Billion US$), 2018 – 2024
Figure 11-1: Quest Diagnostic Net Sales (Million US$), 2011 – 2017
Figure 11-2: Forecast for Quest Diagnostic Net Sales (Million US$), 2018 – 2024
Figure 12-1: Becton, Dickinson and Company Net Sales (Million US$), 2010 – 2017
Figure 12-2: Forecast for Becton, Dickinson and Company Net Sales (Million US$), 2018 – 2024
Figure 13-1: Johnson & Johnson (DePuy Synthes) Net Sales (Billion US$), 2011 - 2017
Figure 13-2: Forecast for Johnson & Johnson (DePuy Synthes) Net Sales (Billion US$), 2018 - 2024
Figure 14-1: Global Health Observatory data Total death by diseases (Million) 2015
List of Tables
Table 15 1: Barriers to Adoption & Scale-up of POC Technologies
Table 15 2: Technical, Administrative & Operational Barriers of POC Tests in Low & Middle Income Countries
Table 15 3: Health System Related Barriers of POC Tests in Low & Middle Income Countries
Table 15 4: Economic Barriers of POC Tests in Low & Middle Income Countries

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report